Results 1 to 10 of about 2,197 (111)

Non-surgical treatment for ductal carcinoma in situ of the breasts – a prospective study on patient's perspective [PDF]

Cancer Treatment and Research Communications, 2021
Introduction: Several ongoing trials are currently investigating the feasibility and non-inferiority of active surveillance for managing low-risk DCIS.
Michael Co, Andrea Lee, Ava Kwong
doaj   +3 more sources

Co-existing malignant lesions in atypical ductal hyperplasia – Pathology, probability, predictors and prognosis [PDF]

Asian Journal of Surgery, 2020
Summary: Background: Atypical ductal hyperplasia (ADH) is known to be associated with underlying malignant breast conditions. Previous studies have shown that up to 40% of ADH found in core needle biopsy of the breasts had undiagnosed malignant lesions ...
Michael Co, Tony Shek, Ava Kwong
doaj   +3 more sources

Ductal carcinoma in situ diagnosed using an ultrasound-guided 14-gauge core needle biopsy of breast masses: can underestimation be predicted preoperatively? [PDF]

Ultrasonography, 2014
Purpose: This study was designed to determine the rate of ductal carcinoma in situ (DCIS) underestimation diagnosed after an ultrasound-guided 14-gauge core needle biopsy (US-14G- CNB) of breast masses and to compare the clinical and imaging ...
Sung Hee Park, Min Jung Kim, Soo Jin Kim, Eun-Kyung Kim   +3 more
doaj   +4 more sources

Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study

Breast, 2022
Background and aim: The natural history of ductal carcinoma in situ (DCIS) is poorly understood. The aim of this cohort study was to determine the outcomes of women who had no surgery for screen-detected DCIS in the 6 months following diagnosis. Methods:
Anthony J. Maxwell, Bridget Hilton, Karen Clements, David Dodwell, Joanne Dulson-Cox, Olive Kearins, Cliona Kirwan, Janet Litherland, Senthurun Mylvaganam, Elena Provenzano, Sarah E. Pinder, Elinor Sawyer, Abeer M. Shaaban, Nisha Sharma, Hilary Stobart, Matthew G. Wallis, Alastair M. Thompson   +16 more
doaj   +1 more source

Carcinoma ductal in situ da mama: critérios para diagnóstico e abordagem em hospitais públicos de Belo Horizonte Approach of ductal carcinoma in situ of the breast in three public hospitals in Belo Horizonte

Revista Brasileira de Ginecologia e Obstetrícia, 2006
OBJETIVOS: avaliar os aspectos clínicos, radiológicos, anátomo-patológicos e terapêuticos de uma série de casos de carcinoma ductal in situ (CDIS) da mama de pacientes atendidos em três hospitais públicos de Belo Horizonte (MG).
Marcio de Almeida Salles, Marco Antonio Rodrigues Freire Matias, Amanda Arantes Perez, Helenice Gobbi   +3 more
doaj   +1 more source

Clinical Predictors of Upstaging to Invasive Cancer Postoperatively in Patients Diagnosed with Ductal Carcinoma In Situ before Surgery

Journal of Surgical Ultrasound, 2019
Purpose: Upstaging to invasive cancer (IC) is often found after surgery in those patients diagnosed with ductal carcinoma in situ (DCIS) and who underwent preoperative needle biopsy.
Kwan Ho Lee, Jeong Woo Han, Eun Young Kim, Ji Sup Yun, Yong Lai Park, Chan Heun Park   +5 more
doaj   +1 more source

Treinamento e critérios padronizados aprimoram o diagnóstico de lesões pré-malignas da mama Training and standardized criteria improve the diagnosis of premalignant breast lesions

Revista Brasileira de Ginecologia e Obstetrícia, 2008
OBJETIVO: analisar a variabilidade interobservador no diagnóstico histopatológico de lesões mamárias consideradas pré-malignas antes e após o treinamento com o uso de critérios diagnósticos padronizados.
Marcio de Almeida Salles, Agostinho Pinto Gouvêa, Daniela Savi, Marco Aurélio Figueiredo, Ramão Tavares Neto, Rodrigo Assis de Paula, Helenice Gobbi   +6 more
doaj   +1 more source

Ciclooxigenase-2 nos carcinomas ductais de mama invasivos com componente ductal in situ e no epitélio adjacente Cyclooxygenase-2 in invasive ductal carcinoma with ductal component in situ and in adjacent epithelium

Revista Brasileira de Ginecologia e Obstetrícia, 2007
OBJETIVO: avaliar a presença da ciclooxigenase-2 (COX-2) nos carcinomas de mama ductal in situ (CDIS) e ductal invasivo (CDI), no estroma adjacente normal e no epitélio.
Vilmar Marques de Oliveira, Maria Marta Martins, Adrienne Pratti Lucarelli, Giuliana Cássia Morrone Taromaru, José Francisco Rinaldi, Maria Antonieta Longo Galvão Silva, Sebastião Piato   +6 more
doaj   +1 more source

Reação anafilática ao corante azul patente durante a biópsia do linfonodo sentinela em câncer de mama inicial: relato de caso Anaphylactic reaction to patent blue dye during sentinel lymph node biopsy in early-stage breast cancer: a case report

Revista Brasileira de Ginecologia e Obstetrícia, 2006
A biópsia do linfonodo sentinela no tratamento do câncer de mama vem substituindo a linfadenectomia em casos iniciais. Este tratamento pode ser realizado com o corante azul vital e/ou radiofármaco.
Julia Yoriko Shinzato, Ana Carolina Pereira Marcaccini, Angélica de Fátima de Assunção Braga, Arneth Rodrigues Ribeiro, José Eduardo Marco Rubio, João Paulo Dias de Souza   +5 more
doaj   +1 more source

Personalizing the Treatment of Women with Ductal Carcinoma In Situ (DCIS) Using the DCIS Score: A Qualitative Study on Score Use

Current Oncology
Background: A twelve-gene molecular expression assay (DCIS score) may help guide radiation oncology treatment under specific circumstances. We undertook a study to examine radiation oncologist (RO), surgeon, and decision maker views on implementing the ...
Mary Ann O’Brien, Lawrence Paszat, Tutsirai Makuwaza, Cindy Fong, Eileen Rakovitch   +4 more
doaj   +1 more source